SCHEMBL7822613

SCHEMBL7822613

CCN(CC)CCCn1cc(C2=C(c3c[nH]c4ccc(OC)cc34)C(=O)NC2=O)c2ccccc21

nearest known ligand 0.73

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PRKD1 Q15139 2/20 0.73
TDP1 Q9NUW8 2/20 0.73
PRKACA P17612 10/20 0.65
PRKACG P22612 10/20 0.65
PRKACB P22694 10/20 0.65
GSK3B P49841 4/20 0.65
CDK4 P11802 3/20 0.65
CCND1 P24385 3/20 0.65
PIM1 P11309 2/20 0.65
PRKCA P17252 2/20 0.65
CCNB2 O95067 2/20 0.65
CDK1 P06493 2/20 0.65
CCNB1 P14635 2/20 0.65
CCNB3 Q8WWL7 2/20 0.65
MEN1 O00255 1/20 0.65
PRKD3 O94806 1/20 0.65
CCNE2 O96020 1/20 0.65
TP53 P04637 1/20 0.65
PRKCG P05129 1/20 0.65
CYP1A2 P05177 1/20 0.65

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9086409 0.94 PRKD1 (0.74) PRKD1TDP1PRKACAPRKACGPRKACB
SCHEMBL7815373 0.93 PRKD1 (0.84) PRKD1TDP1PRKACAPRKACGPRKACB
SCHEMBL7823912 0.93 PRKD1 (0.65) PRKD1TDP1PRKACAPRKACGPRKACB
SCHEMBL9086275 0.92 PRKD1 (0.73) PRKD1TDP1PRKACAPRKACGPRKACB
SCHEMBL7823817 0.91 PRKD1 (0.87) PRKD1TDP1PRKACAPRKACGPRKACB
SCHEMBL9087587 0.89 PRKD1 (0.68) PRKD1TDP1PRKACAPRKACGPRKACB
SCHEMBL7826095 0.88 PRKACA (0.81) PRKD1TDP1PRKACAPRKACGPRKACB
SCHEMBL7826493 0.88 PRKD1 (0.73) PRKD1TDP1PRKACAPRKACGPRKACB
SCHEMBL9087474 0.88 PRKD1 (0.78) PRKD1TDP1PRKACAPRKACGPRKACB
SCHEMBL9087097 0.86 PRKD1 (0.68) PRKD1TDP1PRKACAPRKACGPRKACB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0397060-B1 Maleinimide derivatives and their use as medicines GOEDECKE AG (DE) 2001-11-21 EP claimed
EP-0397060-B1 Maleinimide derivatives and their use as medicines GOEDECKE AG (DE) 2001-11-21 EP disclosed
US-5516915-A Bis-(1H-indol-3-yl)-maleinimide derivatives, processes for the preparation thereof and pharmaceutical compositions containing them GOEDECKE AKTIENGESELLSCHAFT (DE) 1996-05-14 US disclosed
US-5380746-A Bis-(1H-indol-3-YL)-maleinimide derivatives, processes for the preparation thereof and pharmaceutical compositions containing them GOEDECKE AKTIENGESELLSCHAFT (DE) 1995-01-10 US disclosed
EP-0397060-A2 Maleinimide derivatives and their use as medicines GÖDECKE AKTIENGESELLSCHAFT (DE) 1990-11-14 EP disclosed